Yes, other incretins have some of these effects, but its the magnitude of the effect that is so profound, especially looking at weight loss and lipids for example
Scaling safely takes 26 months
Abdominal Pain: Some users report mild to moderate abdominal pain
By week six to eight, your body enters a more consistent fat-loss phase as metabolism adjusts and caloric deficit deepens through sustained appetite suppression
The GLP-1-RA group was associated with reduction in acetazolamide dosage at M6 (\(\beta\)= 288.15, 95% CI 553.09, 23.22, p = 0.03), which did not withstand the adjustment for weight loss
Canadian approval typically follows US approval by 1-2 years for obesity medications